Tellgen Corporation (SHE:300642)

China flag China · Delayed Price · Currency is CNY
20.20
+0.35 (1.76%)
Jan 23, 2026, 3:04 PM CST
46.91%
Market Cap3.23B
Revenue (ttm)373.48M
Net Income (ttm)15.92M
Shares Out159.86M
EPS (ttm)0.10
PE Ratio205.69
Forward PEn/a
Dividend0.15 (0.74%)
Ex-Dividend DateMay 20, 2025
Volume4,307,880
Average Volume7,707,165
Open20.74
Previous Close19.85
Day's Range19.88 - 20.74
52-Week Range11.51 - 32.80
Beta0.44
RSI53.26
Earnings DateApr 25, 2026

About Tellgen

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2003
Employees 522
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300642
Full Company Profile

Financial Performance

In 2024, Tellgen's revenue was 436.78 million, a decrease of -19.53% compared to the previous year's 542.81 million. Earnings were 34.53 million, a decrease of -61.37%.

Financial Statements